Wang Rui's study showed that in a mouse CRC model, Treg infiltration increased after treatment with a PD-1 inhibitor, and proprotein convertase subtilisin/kexin type 9 (PCSK9) expression was enhanced. The gene discussed is PCSK9; the disease is colorectal carcinoma.